Yükleniyor... / Loading...
This study sets up an Italian registry and biobank for collecting biological samples and carrying out genetic profiling of eligible patients who have any type of ML (isolated, syndromic, congenital or acquired). Individuals aged 0-100 with any form of ML may take part. Conducted by Fondazione Policlinico Universitario Agostino Gemelli IRCCS, this study without an assigned phase is currently recruiting participants.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
Inclusion Criteria: 1. Age 0-100 years 2. Signed informed consent. 3. Individuals with any type of ML (isolated, syndromic, congenital or acquired, with or without molecular confirmation) identified by participating centers Exclusion Criteria: * Patients whose clinical picture is not compatible with points a) (b) and (c) of the inclusion criteria, as assessed by the Investigator.